Gilead Sciences | GILD - Процентный доход





Процентный доход Изменить Дата
AbbVie USD 59M 13M 2025-12
Agios Pharmaceuticals USD 12.41M 959K 2025-12
ALKERMES USD 8.54M 3.59M 2026-03
Alnylam Pharmaceuticals USD 26.63M 2.05M 2025-12
Biogen USD 37.9M 700K 2026-03
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Eli Lilly USD 65M 25M 2025-09
Gilead Sciences USD 95M 7M 2025-12
GlaxoSmithKline GBP 22M 96M 2026-03
Glaxosmithkline GBP 22M 4M 2026-03
Incyte USD 33.69M 2.93M 2026-03
J&J USD 2.14 237M 2026-03
Merck USD 69M 27M 2025-12
Moderna USD 70M 3M 2025-12
Pfizer USD 115M 51M 2026-03
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 193.3M 18.2M 2025-12
Sanofi EUR 33M 81M 2025-12
Sarepta Therapeutics USD 8.74M 359K 2025-12
United Therapeutics USD 43.2M 3.2M 2025-12
Vertex Pharmaceuticals USD 114.8M 7.1M 2026-03